Form 4: Elanco Director Michael J. Harrington Receives Stock Grant

Elanco Animal Health director Michael J. Harrington received 18,169 shares of common stock as part of an annual equity award.

Summary

• Michael J. Harrington, a director at Elanco Animal Health, received 18,169 shares of common stock on November 29, 2024.
• This grant was part of an annual equity award for non-employee members of the company's Board of Directors.
• Following this transaction, Mr. Harrington beneficially owns 99,263 shares of Elanco common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock grant to a director) which is generally viewed positively as it aligns director interests with shareholders. There are no negative implications.

Positives

• The grant of stock units aligns the interests of non-employee directors with those of shareholders.
• The equity award is a standard practice for compensating board members.

Industry Context

The granting of stock to board members is a common practice in publicly traded companies to align their interests with those of shareholders and incentivize good governance.

Comparison to Industry Standards

• Stock grants to non-employee directors are a standard practice across the industry, including companies like Zoetis and IDEXX Laboratories.
• The number of shares granted is likely determined by a pre-set formula based on board member compensation policies, which is typical for companies of Elanco's size and market capitalization.

Stakeholder Impact

• The stock grant aligns the interests of the director with those of shareholders.
• The grant does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Elanco, stock grant, equity award, director, Michael J. Harrington, beneficial ownership, Form 4, corporate governance